Andre W. Bourgoyne: Anemia Management as a Comprehensive Hospital Performance Strategy
Andre W. Bourgoyne, Bloodless Program Consultant at UChicago Medicine shared a post on LinkedIn:
“Anemia Management Is a Hospital Performance Strategy – Not Just a Lab Value
Preoperative anemia is one of the strongest predictors of surgical complications, longer hospital stays, and increased mortality.
Yet many hospitals still treat anemia reactively.
Forward-thinking institutions are shifting to Preoperative anemia management initiatives.
Why it matters:
- Fewer transfusions
- Lower complication rates
- Reduced ICU utilization
- Shorter length of stay
- Improved quality metrics
- Stronger financial performance
Optimizing hemoglobin before surgery with IV iron, B12, folate, nutrition, and appropriate EPO support doesn’t just protect patients – it protects institutional outcomes.
Anemia management is:
- Risk reduction
- Cost containment
- Outcome optimization
- Strategic differentiation
Hospitals that strengthen the blood before surgery strengthen their brand, their margins, and their mission.
Stay updated with Hemostasis Today.
-
Aug 14, 2026, 11:40Liz Devlin: When HHT Affects More Than What We Can See
-
Aug 14, 2026, 11:29Archil Jaliashvili: Can Italy Reduce Its Dependence on Imported Plasma
-
Aug 14, 2026, 11:21Osama Alabdi: Never Ignore a Weak Reaction in the Blood Bank
-
Aug 14, 2026, 11:14Yohan Santin: How Lysosomal Dysfunction Drives Cardiac Aging
-
Aug 14, 2026, 11:06Nicolas Schommer: When Neutrophils Turn Metabolic Stress Into Organ Injury
-
Aug 14, 2026, 10:49Pablo Corral: Can One Infusion Lower LDL for Years
-
Aug 14, 2026, 08:17Maha Othman: Celebrating Research and Collaboration at the Sinclair Cancer Research Institute 2026 Annual Retreat
-
Aug 14, 2026, 06:26Delivering Gene Therapy in Hemophilia – ISTH
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children